C.J. van Boxtel

1.1k total citations
47 papers, 893 citations indexed

About

C.J. van Boxtel is a scholar working on Pharmacology, Public Health, Environmental and Occupational Health and Analytical Chemistry. According to data from OpenAlex, C.J. van Boxtel has authored 47 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 8 papers in Public Health, Environmental and Occupational Health and 8 papers in Analytical Chemistry. Recurrent topics in C.J. van Boxtel's work include Analytical Methods in Pharmaceuticals (8 papers), Malaria Research and Control (7 papers) and Pharmacological Effects and Assays (5 papers). C.J. van Boxtel is often cited by papers focused on Analytical Methods in Pharmaceuticals (8 papers), Malaria Research and Control (7 papers) and Pharmacological Effects and Assays (5 papers). C.J. van Boxtel collaborates with scholars based in Netherlands, Vietnam and United States. C.J. van Boxtel's co-authors include B. Oosterhuis, Richard P. Koopmans, Michiel A. van Agtmael, John T. Wilson, René E. Jonkers, B. Santoso, I. Ralph Edwards, Robert Mull, Folke Sjöqvist and C. P. Engelfriet and has published in prestigious journals such as The Journal of Experimental Medicine, Antimicrobial Agents and Chemotherapy and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

C.J. van Boxtel

47 papers receiving 824 citations

Peers

C.J. van Boxtel
M. Hümpel Germany
Menger Chung United States
F Perlı́k Czechia
Edward J. Randinitis United States
C.J. van Boxtel
Citations per year, relative to C.J. van Boxtel C.J. van Boxtel (= 1×) peers Marianne Frisk‐Holmberg

Countries citing papers authored by C.J. van Boxtel

Since Specialization
Citations

This map shows the geographic impact of C.J. van Boxtel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.J. van Boxtel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.J. van Boxtel more than expected).

Fields of papers citing papers by C.J. van Boxtel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.J. van Boxtel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.J. van Boxtel. The network helps show where C.J. van Boxtel may publish in the future.

Co-authorship network of co-authors of C.J. van Boxtel

This figure shows the co-authorship network connecting the top 25 collaborators of C.J. van Boxtel. A scholar is included among the top collaborators of C.J. van Boxtel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.J. van Boxtel. C.J. van Boxtel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Boxtel, C.J. van, et al.. (2003). Pharmacokinetics of a Single Oral Dose of Baclofen in Pediatric Patients With Gastroesophageal Reflux Disease. Therapeutic Drug Monitoring. 25(1). 93–98. 19 indexed citations
3.
Zwinderman, A. H., et al.. (2003). Distinct actions of prednisolone and dexamethasone towards osteocalcin and eosinophilic cationic protein in assumed clinically equivalent doses: a study in healthy men. European Journal of Clinical Pharmacology. 58(11). 733–737. 6 indexed citations
4.
Mulder, W., Suzanne de Klerk, Jos J. Settels, & C.J. van Boxtel. (2002). Beat-to-Beat Measurement of Cardiovascular Effects of a Single Subcutaneous Dose of Terbutaline in Healthy Subjects. Clinical Drug Investigation. 22(9). 593–600. 1 indexed citations
5.
Agtmael, Michiel A. van, et al.. (1999). Multiple dose pharmacokinetics of artemether in Chinese patients with uncomplicated falciparum malaria. International Journal of Antimicrobial Agents. 12(2). 151–158. 77 indexed citations
6.
Koolen, Marijn, et al.. (1999). Pharmacokinetic/Pharmacodynamic Modelling of the Eosinopenic and Hypokalemic Effects of Formoterol and Theophylline Combination in Healthy Men. Pulmonary Pharmacology & Therapeutics. 12(3). 185–192. 6 indexed citations
7.
Eggelte, Teunis A., Michiel A. van Agtmael, Tri Vuong, & C.J. van Boxtel. (1999). The development of an immunoassay for the detection of artemisinin compounds in urine.. American Journal of Tropical Medicine and Hygiene. 61(3). 449–456. 12 indexed citations
8.
Agtmael, Michiel A. van, et al.. (1998). The contribution of the enzymes CYP2D6 and CYP2C19 in the demethylation of artemether in healthy subjects. European Journal of Drug Metabolism and Pharmacokinetics. 23(3). 429–436. 26 indexed citations
9.
Vries, Peter J. de, et al.. (1997). The pharmacokinetics of a single dose of artemisinin in subjects with liver cirrhosis. Tropical Medicine & International Health. 2(10). 957–962. 8 indexed citations
11.
Kager, Piet A., MJ Schultz, E.E. Zijlstra, Benno van den Berg, & C.J. van Boxtel. (1994). Arteether administration in humans: preliminary studies of pharmacokinetics, safety and tolerance. Transactions of the Royal Society of Tropical Medicine and Hygiene. 88. 53–54. 36 indexed citations
12.
Koopmans, Richard P., et al.. (1993). The effect of oxprenolol dosage time on its pharmacokinetics and haemodynamic effects during exercise in man. European Journal of Clinical Pharmacology. 44(2). 171–176. 8 indexed citations
13.
Jonkers, René E., et al.. (1992). Quantification of metoprolol Beta2-adrenoceptor antagonism in asthmatic patients by pharmacokinetic-pharmacodynamic modelling. Pulmonary Pharmacology. 5(1). 31–38. 11 indexed citations
14.
Koopmans, Richard P., et al.. (1992). Time-dependent effects of dexamethasone administration on the suppression of plasma hydrocortisone, assessed with a pharmacokinetic model.. Journal of Pharmacology and Experimental Therapeutics. 262(2). 503–508. 20 indexed citations
15.
Jonkers, René E., et al.. (1990). Debrisoquine phenotype and the pharmacokinetics and beta-2 receptor pharmacodynamics of metoprolol and its enantiomers.. Journal of Pharmacology and Experimental Therapeutics. 256(3). 959–966. 35 indexed citations
16.
Jonkers, René E., C.J. van Boxtel, Richard P. Koopmans, & B. Oosterhuis. (1989). A nonsteady-state agonist antagonist interaction model using plasma potassium concentrations to quantify the beta-2 selectivity of beta blockers.. Journal of Pharmacology and Experimental Therapeutics. 249(1). 297–302. 13 indexed citations
17.
Koopmans, Richard P., Jasper Dingemanse, Meindert Danhof, G.P.M. Horsten, & C.J. van Boxtel. (1988). Pharmacokinetic-pharmacodynamic modeling of midazolam effects on the human central nervous system. Clinical Pharmacology & Therapeutics. 44(1). 14–22. 45 indexed citations
18.
Koopmans, Richard P., B. Oosterhuis, John M. Karemaker, J. Wemer, & C.J. van Boxtel. (1988). Pharmacokinetic-pharmacodynamic modelling of oxprenolol in man using continuous non-invasive blood pressure monitoring. European Journal of Clinical Pharmacology. 34(4). 395–400. 7 indexed citations
19.
Ruers, T.J.M., Wim A. Buurman, C.J. van Boxtel, Josje van der Linden, & G. Kootstra. (1987). Immunohistological observations in rat kidney allografts after local steroid administration.. The Journal of Experimental Medicine. 166(5). 1205–1220. 22 indexed citations
20.
Oosterhuis, B., et al.. (1984). Pharmacokinetic-pharmacodynamic modeling of prednisolone-induced lymphocytopenia in man.. Journal of Pharmacology and Experimental Therapeutics. 229(2). 539–546. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026